Northpointe Capital’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-507,795
Closed -$11.1M 238
2015
Q4
$11.1M Hold
507,795
1.46% 9
2015
Q3
$11.1M Sell
507,795
-157,888
-24% -$3.95M 1.45% 9
2015
Q2
$16.4M Sell
665,683
-294,242
-31% -$6.57M 1.93% 3
2015
Q1
$19.7M Buy
959,925
+21,709
+2% +$421K 2.13% 2
2014
Q4
$18.7M Sell
938,216
-71,871
-7% -$1.23M 2.25% 1
2014
Q3
$14.9M Buy
1,010,087
+162,525
+19% +$2.59M 1.58% 2
2014
Q2
$15.6M Buy
847,562
+65,383
+8% +$1.09M 1.5% 2
2014
Q1
$14.7M Buy
782,179
+60,203
+8% +$1.23M 1.49% 11
2013
Q4
$13.5M Sell
721,976
-153,465
-18% -$2.23M 1.19% 20
2013
Q3
$9.61M Sell
875,441
-29,830
-3% -$294K 1.13% 26
2013
Q2
$8.6M Buy
+905,271
New +$7.89M 0.99% 30

Other funds holding ATRC

Northpointe Capital's ATRC Position: Q1 2016 in Review

Northpointe Capital sold out of AtriCure (ATRC) in Q1 2016, closing a stake of 507,795 shares — an estimated $11.1M sold.

Northpointe Capital first reported a position in ATRC in Q2 2013 and held it in 11 quarters. The position peaked at $19.7M in Q1 2015. 113 funds tracked by Wall St. Rank hold ATRC as of Q1 2016.

  • Northpointe Capital reported no remaining AtriCure position as of Q1 2016 after selling out during the quarter.
  • Northpointe Capital sold 507,795 AtriCure shares in Q1 2016, an estimated $11.1M.
  • Northpointe Capital first reported a position in AtriCure in Q2 2013 and held it in 11 quarters.
  • Northpointe Capital's AtriCure position peaked at $19.7M in Q1 2015.
  • 113 funds tracked by Wall St. Rank held AtriCure as of Q1 2016.

Based on Northpointe Capital's 13F filing for Q1 2016, filed 28 Apr 2016.